Health
First in Human Study with Novel Antisense Oligonucleotide – Mirage News
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans. Inhibition of miR-92a…
A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans. Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics. Click here to read the article for free through September 12, 2020.
“Based on documented, promising therapeutic potential, locked nucleic a…
-
Noosa News19 hours agoPolice swarm rural road after man shot during incident near Murwillumbah
-
Noosa News22 hours agoBody found after suspicious blaze destroys Citipointe Charity Warehouse in Durack, Brisbane
-
Business23 hours agoWhere will Nvidia be in 5 years?
-
Noosa News22 hours agoFamily of Kimura Dixon pay tribute to ‘amazing father’ killed in West End retaining wall collapse